2016-2026年胃腸病學領域的合作與授權協議

Gastrointestinal Collaboration and Licensing Deals 2016-2026

出版日期: 2026年10月01日 | 出版商:

Current Partnering | 英文 250+ Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

讓我們透過 438 個案例研究，利用有關合作關係和許可協議的信息，來了解胃腸病學領域的合作趨勢。

《2016-2026 年胃腸病學領域的合作與許可協議》提供了有關 438 項與消化器官系統資產、技術和開發計劃相關的合作交易的全面資訊。

我們在胃腸道領域的合作涵蓋了廣泛的治療適應症、技術和開發階段，我們的交易範圍也十分廣泛，從最初的研究合作到授權協議、開發協議和商業化協議。

本報告將這些趨勢匯總到一個資源中，使用戶能夠了解哪些公司正在建立合作關係，哪些消化器官系統機會正在吸引關注，交易結構是什麼，披露了哪些財務條款，以及交易如何根據治療適應症、技術和開發階段而有所不同。

這份報告不只是簡單地列出了交易清單；它結合了全面的市場交易分析和財務基準、主要交易者的信息、詳細的交易記錄以及公開的合約文件。

本報告為胃腸病學領域的業務發展、許可、研究和評估、公司策略、研發策略、競爭情報分析以及參與合作的法律團隊提供了實用的資訊來源和基準。

了解胃腸病學領域的合作趨勢

本報告分析了2016年至2026年胃腸病學領域的交易情況，內容包括：

胃腸病領域合作的年度趨勢
按交易類型分類的交易趨勢
產業部門
合作關係發展階段
技術類型
胃腸道領域的治療適應症
消化器官系統領域最活躍的交易商
根據已披露的交易金額，主要交易
胃腸病學領域合作活動的趨勢
這使用戶能夠確定他們的活動集中在哪些方面，並了解哪些公司、技術、開發階段和治療領域正在吸引合作興趣。
消化器官系統交易的財務狀況基準
財務條款可能因所涉資產、開發階段、技術、授予的權利以及交易的整體結構而有很大差異。

本報告對已揭露的財務狀況進行了詳細分析，包括以下內容：

交易總額
預付款
里程碑付款
版稅率
透過分析這些基準背後的具體交易，用戶可以更全面地了解所揭露的經濟數據背後的經濟狀況。
這為內部基準測試、機會評估、交易準備和談判提供了一個現實的基準。
財務基準只有在結合類似交易的結構和情況進行解讀時才最有用，而不僅僅是作為平均值來解讀。本報告提供了建立這種背景所需的基礎交易資訊。
確定胃腸病學領域的關鍵交易撮合者和潛在的未來合作夥伴。
本報告列出了在胃腸病學領域合作活動最活躍的公司，並提供交易歷史記錄，以便用戶可以調查這些公司過去的活動。

這有助於用戶識別以下內容：

積極尋求胃腸病學領域機會的公司
有潛力的許可和聯合開發合作夥伴
我們曾多次與一些組織合作，共同研究特定胃腸道疾病的適應症。
積極參與開發過程的公司
對特定技術或方法表現出興趣的交易商
競爭對手採取類似的外部創新策略
對於尋求消化器官系統資產和技術合作夥伴的公司而言，過去的交易歷史可以提供寶貴的見解，了解哪些組織對類似的機會表現出了興趣。
比較胃腸道疾病各適應症的協同活動。
胃腸道疾病涵蓋一系列治療適應症，其科學、臨床和商業性趨勢各不相同。
本報告按消化器官系統的治療適應症分析交易，使用戶能夠專注於與特定項目或策略利益最相關的交易，而不是僅依賴廣泛的市場層級基準。
透過結合基於技術和發展階段的分析，用戶可以發現更多有意義的類似交易和潛在的未來合作夥伴關係。
了解胃腸病學領域的合約結構
本報告涵蓋合作關係、授權、開發、研究和其他合作交易。

根據交易詳情和資訊披露，用戶可以調查以下方面：

授予和保留的權利
研發職責
授權權
獨家版權
區域權利
智慧財產
發展和監管義務
負責生產和供應
商業化權利
金錢補償
里程碑和版稅
管治
合約期限和終止條款
這些例子為考慮胃腸病學領域合作的適當框架提供了寶貴的見解。
從實際合約文件中學習
本報告提供了公開可取得的有關選定胃腸道交易的基礎合約文件的途徑。

這些合約提供的資訊遠比簡單的標題公告所能展現的要詳細得多，使用戶能夠檢驗公司如何記錄諸如以下事項：

權利範圍
發展義務
智慧財產
獨家版權
財務狀況
里程碑觸發條件
特許權使用費規定
商業化權利
合約終止及其他協議
對於正在準備或談判胃腸病學領域合作或許可協議的團隊來說，獲取實際的合約措辭可以提供寶貴的見解，了解類似交易的實際結構。
綜合消化器官系統交易目錄
本報告包含一份全面的目錄，收錄了胃腸病學領域的 438 項合作研究和許可協議，為識別相關的領先交易提供了詳細的資訊來源。

在以下條件下可以查看交易記錄：

公司
技術類型
治療指徵
合約揭露狀態
每筆交易都與其底層交易記錄相關聯，從而可以存取詳細的交易資訊和相關的合約文件（如有）。
你會向哪些人推薦這份報告？
業務拓展與授權團隊
識別類似的消化器官系統交易、潛在合作夥伴和相關交易結構。
研究與評估團隊
我們尋找那些在胃腸病學領域積極探索商機，並專注於特定適應症、技術和發展階段的公司。
尋求合作夥伴的生技公司
找出對類似消化器官系統資產或技術表現出明顯興趣的組織。
企業策略與研發策略團隊
我們將了解我們的競爭對手和潛在合作夥伴如何透過外部創新來建立消化器官系統管道。
競爭與市場情報團隊
我們按公司、適應症、開發階段和技術追蹤合作趨勢，以了解不斷變化的策略重點。
法律及交易團隊
我們將仔細審查公開的合約和以往的合約結構，以幫助您準備和談判交易。
我們將市場範圍內的消化器官系統資訊轉化為公司特有的洞察。
符合資格的客戶將收到 Current Partnering 的報告，以及為高階主管量身訂製的合作關係簡報。
本次簡報將說明有關胃腸道領域交易的基礎信息，並根據您的特定資產、技術、適應症或合作目標量身定做。
如有需要，我們可以提供相關的類似交易、潛在合作夥伴關係、競爭對手活動、發展階段分析、交易結構、財務基準、忠誠度分析、合約見解以及其他專門為您情況選擇的資訊。
請索取樣本或聯絡 Current Partnering 討論本報告的內容以及我們是否可以為貴公司提供客製化分析。

The report brings this activity together in one resource, enabling users to understand who is partnering, which gastrointestinal opportunities are attracting interest, how transactions are structured, what financial terms have been disclosed and how dealmaking differs across therapeutic indications, technologies and stages of development.

Rather than simply providing a list of transactions, the report combines market-wide deal analysis with financial benchmarking, leading dealmaker intelligence, detailed transaction records and access to publicly available contract documents where available.

It provides a practical intelligence and benchmarking resource for business development, licensing, search and evaluation, corporate strategy, R&D strategy, competitive intelligence and legal teams involved in gastrointestinal partnering.

Understand the gastrointestinal partnering landscape

The report analyzes gastrointestinal dealmaking from 2016 to 2026, including:

Trends in gastrointestinal partnering by year
Deal activity by deal type
Industry sector
Stage of development at the time of partnering
Technology type
Gastrointestinal therapeutic indication
Most active gastrointestinal dealmakers
Leading deals by disclosed value
How gastrointestinal partnering activity is evolving
This enables users to identify where activity is concentrated and understand which companies, technologies, development stages and therapeutic areas are attracting partnering interest.
Benchmark gastrointestinal deal financials
Financial terms can vary considerably according to the asset, development stage, technology, rights granted and overall transaction structure.

The report provides dedicated analysis of disclosed financial terms, including:

Headline deal values
Upfront payments
Milestone payments
Royalty rates
Users can then investigate the individual transactions behind these benchmarks to understand the wider context surrounding the disclosed economics.
This provides real-world reference points for internal benchmarking, opportunity assessment, deal preparation and negotiation.
Financial benchmarks are most useful when interpreted alongside the structure and circumstances of comparable transactions rather than as standalone averages, and the report provides the underlying deal intelligence needed to establish that context.
Identify leading gastrointestinal dealmakers and prospective partners
The report identifies the most active companies in gastrointestinal partnering and provides transaction histories that enable users to investigate their previous activity.

This can help users identify:

Companies actively seeking gastrointestinal opportunities
Prospective licensing and collaboration partners
Organizations repeatedly partnering in particular gastrointestinal indications
Companies active at relevant stages of development
Dealmakers demonstrating interest in specific technologies or approaches
Competitors pursuing similar external innovation strategies
For companies seeking to partner a gastrointestinal asset or technology, previous transaction activity can provide useful evidence of which organizations have demonstrated an appetite for comparable opportunities.
Compare partnering activity across gastrointestinal indications
Gastrointestinal disease encompasses multiple therapeutic indications with differing scientific, clinical and commercial dynamics.
The report analyzes deals by gastrointestinal therapeutic indication, allowing users to move beyond broad market-level benchmarks and focus on transactions most relevant to a particular program or strategic interest.
Combined with analysis by technology and development stage, this enables users to identify more meaningful comparable transactions and prospective partners.
Understand how gastrointestinal agreements are structured
The report includes collaboration, licensing, development, research and other partnering transactions.

Depending on the transaction and available disclosure, users can investigate areas including:

Rights granted and retained
Research and development responsibilities
Licensing rights
Exclusivity
Geographic rights
Intellectual property
Development and regulatory obligations
Manufacturing and supply responsibilities
Commercialization rights
Financial consideration
Milestones and royalties
Governance
Term and termination provisions
These real-world examples provide useful reference points when considering the appropriate structure for a gastrointestinal partnership.
Learn from real-world contract documents
Where publicly available, the report provides access to underlying contract documents for selected gastrointestinal transactions.

These agreements can provide substantially more detail than headline announcements alone, enabling users to examine how companies have documented areas such as:

Scope of rights
Development obligations
Intellectual property
Exclusivity
Financial terms
Milestone triggers
Royalty provisions
Commercialization rights
Termination and other negotiated provisions
For teams preparing or negotiating a gastrointestinal collaboration or licensing agreement, access to real contract language provides valuable insight into how comparable deals have been structured in practice.
Comprehensive gastrointestinal deal directory
The report includes a comprehensive directory of 438 gastrointestinal collaboration and licensing deals, providing a detailed resource for identifying relevant precedent transactions.

Deals can be reviewed by:

Company
Technology type
Therapeutic indication
Contract availability
Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
Who should use this report?
Business Development and Licensing teams
Identify comparable gastrointestinal transactions, prospective partners and relevant deal structures.
Search and Evaluation teams
Understand which companies are actively seeking gastrointestinal opportunities across particular indications, technologies and development stages.
Biotechnology Companies Seeking Partners
Identify organizations with demonstrated interest in comparable gastrointestinal assets and technologies.
Corporate and R&D Strategy teams
Understand how competitors and prospective partners are building gastrointestinal pipelines through external innovation.
Competitive and Market Intelligence teams
Track partnering activity by company, indication, development stage and technology to understand evolving strategic priorities.
Legal and Transaction teams
Review publicly available contracts and precedent agreement structures to support transaction preparation and negotiation.
Turn market-wide gastrointestinal intelligence into company-specific insight
For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
The briefing applies the underlying gastrointestinal deal intelligence to the customer's own asset, technology, indication or partnering objectives.
Depending on requirements, this can include relevant comparable transactions, prospective partners, competitor activity, development-stage analysis, deal structures, financial benchmarks, royalty analysis, contract insights and other intelligence selected specifically for the client's situation.
Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.